According to TechSci Research India Point of Care Diagnostics Market was valued at USD 628.32 Million in 2024 and is anticipated to hit USD 1,024.57 Million by 2030 with a CAGR of 8.45% during the forecast period. Government Initiatives Driving Growth Government support is central to the expansion of point of care diagnostics in India. The National Health Mission (NHM) focuses on bridging healthcare gaps in rural and underserved areas. By promoting the use of quick diagnostic devices, the NHM ensures that patients in remote regions get access to faster and more reliable test results. The Pradhan Mantri Jan Arogya Yojana (PMJAY) under the Ayushman Bharat scheme is another game changer. It provides affordable healthcare coverage for millions and encourages adoption of innovative diagnostic tools. The inclusion of POC diagnostics under this initiative improves accessibility and ensures efficient patient management. Investments in medical technology innovation, public-private partnerships, and digital health initiatives also support the sector. These actions are creating a favorable ecosystem for diagnostics companies to expand their footprint. Rising Health Awareness and Its Impact The Indian population is becoming more conscious about preventive healthcare. A surge in chronic conditions like diabetes, hypertension, and cardiovascular diseases has shifted attention towards early detection. The COVID-19 pandemic also accelerated awareness regarding timely testing and monitoring. Consumers are now more willing to spend on regular check-ups and self-monitoring devices. This behavioral shift aligns with the core strengths of POC diagnostics, which deliver quick and reliable results without requiring large laboratory setups. Increased adoption of home-based glucose monitors and rapid testing kits reflects this trend. Browse market data Figures spread through 185+ Pages and an in-depth TOC on "India Point of Care Diagnostics Market” - https://www.techsciresearch.com/report/india-point-of-care-diagnostics-market/27688.html

1. INDIA POINT OF CARE DIAGNOSTICS MARKET 2024-2030: KEY PLAYERS,
SEGMENTS, AND FORECASTS

2. Table: India Point of Care Diagnostics Market Snapshot (2024-2030)
Parameter Details
Market Size (2024) USD 628.32 Million
Forecast CAGR (2024-
2030)
8.45%
Key Growth Drivers
Government healthcare schemes, rising chronic diseases, growing
health awareness
Top Product Segment Glucose Testing
Fastest Growing Region North India
Key End Users Hospitals, diagnostic centers, home healthcare

3. Parameter Details
Leading Companies Roche, Abbott, Siemens, BD, Qiagen, BioMérieux
According to TechSci Research India Point of Care Diagnostics Market was valued at USD 628.32
Million in 2024 and is anticipated to hit USD 1,024.57 Million by 2030 with a CAGR of 8.45% during
the forecast period.
Government Initiatives Driving Growth
Government support is central to the expansion of point of care diagnostics in India. The National
Health Mission (NHM) focuses on bridging healthcare gaps in rural and underserved areas. By
promoting the use of quick diagnostic devices, the NHM ensures that patients in remote regions
get access to faster and more reliable test results.

4. The Pradhan Mantri Jan Arogya Yojana (PMJAY) under the Ayushman Bharat scheme is another
game changer. It provides affordable healthcare coverage for millions and encourages adoption
of innovative diagnostic tools. The inclusion of POC diagnostics under this initiative improves
accessibility and ensures efficient patient management.
Investments in medical technology innovation, public-private partnerships, and digital health
initiatives also support the sector. These actions are creating a favorable ecosystem for
diagnostics companies to expand their footprint.
Browse market data Figures spread through 185+ Pages and an in-depth TOC on "India Point
of Care Diagnostics Market” - https://www.techsciresearch.com/report/india-point-of-care-
diagnostics-market/27688.html
Rising Health Awareness and Its Impact
The Indian population is becoming more conscious about preventive healthcare. A surge in
chronic conditions like diabetes, hypertension, and cardiovascular diseases has shifted attention
towards early detection. The COVID-19 pandemic also accelerated awareness regarding timely
testing and monitoring.

5. Consumers are now more willing to spend on regular check-ups and self-monitoring devices. This
behavioral shift aligns with the core strengths of POC diagnostics, which deliver quick and
reliable results without requiring large laboratory setups. Increased adoption of home-based
glucose monitors and rapid testing kits reflects this trend.
Market Segmentation
By Product
o Glucose Testing
o Hb1Ac Testing
o Coagulation Testing
o Fertility/Pregnancy
o Infectious Disease
o Cardiac Markers
o Thyroid Stimulating Hormone
o Hematology

6. o Primary Care Systems
o Others
By End Use
o Clinics
o Hospitals
o Home
o Assisted Living Healthcare Facilities
o Laboratory
By Region
o East India
o West India
o North India

7. o South India
Download Free Sample Report - https://www.techsciresearch.com/sample-
report.aspx?cid=27688
Factors Supporting Market Expansion
Growing Burden of Chronic Diseases
Chronic diseases are one of the biggest drivers of the point of care diagnostics market in India.
The country has one of the world’s largest diabetic populations, with millions requiring regular
monitoring of blood glucose levels. Diabetes is no longer confined to older age groups, as
younger people are also being diagnosed due to lifestyle changes, sedentary habits, and poor
dietary patterns. Apart from diabetes, cardiovascular diseases are increasing at an alarming
pace. High blood pressure, obesity, and cholesterol-related conditions demand continuous
testing and early detection to avoid complications. Point of care devices allow patients and
doctors to track these conditions with minimal delay, improving treatment outcomes. The growing
incidence of chronic diseases ensures that demand for diagnostic monitoring tools remains steady
across both urban and rural India.

8. Technological Advancements
Technology is playing a central role in the expansion of point of care diagnostics. Companies are
moving beyond traditional testing kits to launch portable and connected devices that fit the needs
of today’s consumers. Modern devices are often Bluetooth-enabled and can sync with mobile
apps, providing users with real-time tracking and data storage. This connectivity helps both
patients and doctors maintain accurate health records and improve compliance with treatment
plans. Automated test kits with higher accuracy, reduced turnaround times, and user-friendly
designs are also entering the market. These innovations make testing more reliable and reduce
dependency on laboratory infrastructure, which is particularly valuable in regions with limited
healthcare facilities. As technology advances further, adoption is expected to accelerate among
both healthcare professionals and individual users.
Rising Middle-Class Income
India’s growing middle class is another factor driving demand for diagnostic services. As
disposable income levels rise, more households are prioritizing preventive healthcare and
regular health monitoring. Patients who once delayed testing due to cost concerns are now more
willing to invest in personal diagnostic kits such as glucose monitors, cholesterol testing devices,
and home pregnancy tests. The shift from reactive healthcare to preventive care is becoming
evident across cities and towns. People are increasingly aware that timely testing helps in early

9. diagnosis and lowers long-term treatment costs. This awareness, coupled with better
affordability, has created a favorable environment for the widespread use of point of care
devices.
Expanding Private Healthcare Sector
The private healthcare sector in India is growing rapidly, driven by rising demand for quality
medical services and the limitations of public infrastructure. Private hospitals, clinics, and
diagnostic centers are adopting point of care tools to manage the growing patient load and
provide faster results. These institutions see POC diagnostics as a way to enhance efficiency and
patient satisfaction. For example, rapid diagnostic kits reduce waiting times, allowing doctors to
initiate treatment immediately. The expansion of private healthcare chains into smaller cities and
semi-urban regions is also supporting market penetration. By offering advanced diagnostic tools
closer to patients, private players are ensuring that access to quick and reliable testing is not
restricted to metropolitan areas.
Competitive Landscape
The India Point of Care Diagnostics Market is moderately consolidated, with several multinational
and domestic players competing. Key companies include:
• Roche Products (India) Pvt. Ltd.
• Qiagen India Pvt Ltd.

10. • Danaher Corporation
• Becton Dickinson Private Limited
• BioMérieux
• Siemens Healthcare Private Limited
• Abbott India Ltd
• Trividia Health, Inc.
• Spectra Medical India Pvt Ltd
• AccuBioTech Co., Ltd.
These companies are investing in local manufacturing, distribution networks, and partnerships to
strengthen their reach. The competitive environment also drives product innovation and
affordability.
Opportunities and Future Outlook
• Rural Healthcare Penetration: Significant potential lies in rural and tier-2 cities where
access to laboratories is limited.
• Integration with Digital Platforms: POC devices linked with health apps will gain
traction as telemedicine expands.
• Regulatory Support: Favorable guidelines and fast-track approvals for diagnostics will
help companies introduce new technologies.

11. • Domestic Manufacturing: With government incentives, more companies may set up
production units in India, reducing costs and dependence on imports.
The India POC diagnostics market is expected to reach new heights by 2030, growing steadily at
a CAGR of 8.45%. With both government and private sector support, it is poised to become a
central pillar of the country’s healthcare delivery system.
Why You Should Check Out This Report
1. Comprehensive Market Size Insights – Detailed analysis of the USD 628.32 million
market in 2024 with CAGR projections.
2. Future Growth Forecasts – Data-backed forecast up to 2030 highlighting emerging
opportunities in the Indian healthcare ecosystem.
3. Regional Growth Analysis – Covers North, South, East, and West India with focus on
regional demand patterns.
4. Product Segment Trends – Explains why glucose testing dominates and what categories
are set to grow next.
5. Policy and Government Support – Tracks schemes like NHM and PMJAY that are shaping
diagnostic adoption.
6. Competitive Landscape – Profiles leading players including Roche, Abbott, Siemens,
and Qiagen.

12. 7. Healthcare Behavior Shifts – Insights into how rising health awareness is driving point of
care (POC) diagnostics adoption.
Download Free Sample Report - https://www.techsciresearch.com/sample-
report.aspx?cid=27688
Recent Published Reports -
Medical Examination Lights Market - https://www.techsciresearch.com/report/medical-
examination-lights-market/30715.html
Phosphoramidite Market - https://www.techsciresearch.com/report/phosphoramidite-
market/30718.html
Psoriatic Arthritis Treatment Market - https://www.techsciresearch.com/report/psoriatic-
arthritis-treatment-market/30721.html
Liquid Embolic Agent Market - https://www.techsciresearch.com/report/liquid-embolic-agent-
market/30733.html

13. United States Credentialing Software And Services In Healthcare Market
https://www.techsciresearch.com/report/united-states-credentialing-software-and-services-in-
healthcare-market/30734.html
About Us:
TechSci Research is a management consulting firm focused on market research and advisory
solutions, serving clients across industries worldwide.
At its core, TechSci stands on three values: value, integrity, and insight. Backed by a team of
experienced industry professionals, the firm helps clients discover new opportunities, identify
growth drivers, and find smarter ways to gain market share. Instead of following trends, TechSci
empowers its clients to set them.
Unlike traditional research models, TechSci combines decades of expertise with advanced
technology to deliver sharper, more practical insights. Its reports go beyond raw data—
presenting information in a clear, interactive format that clients can actually use to make informed
decisions.

14. Contact
420 Lexington Avenue,
Suite 300, New York, NY,
United States, 10170
Tel: +13322586602
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com